<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">349216</id>
  <title nil="true"/>
  <common-name>2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl 2-[(7-chloroquinolin-4-yl)amino]benzoate</common-name>
  <description>2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl 2-[(7-chloroquinolin-4-yl)amino]benzoate is a chemical compound with the formula C29H26ClF3N4O2. With an average molecular weight of 555.00 g/mol, 2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl 2-[(7-chloroquinolin-4-yl)amino]benzoate is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>3043307</pubchem-id>
  <chemical-formula>C29H26ClF3N4O2</chemical-formula>
  <weight>555</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T13:41:58Z</created-at>
  <updated-at type="dateTime">2026-08-31T13:41:58Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1CN(CCN1CCOC(=O)C2=CC=CC=C2NC3=C4C=CC(=CC4=NC=C3)Cl)C5=CC=CC(=C5)C(F)(F)F</moldb-smiles>
  <moldb-formula>C29H26ClF3N4O2</moldb-formula>
  <moldb-inchi>InChI=1S/C29H26ClF3N4O2/c30-21-8-9-23-26(10-11-34-27(23)19-21)35-25-7-2-1-6-24(25)28(38)39-17-16-36-12-14-37(15-13-36)22-5-3-4-20(18-22)29(31,32)33/h1-11,18-19H,12-17H2,(H,34,35)</moldb-inchi>
  <moldb-inchikey>XBVLEIVXSOQLFB-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">554.1696383</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>7.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM345109</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl 2-[(7-chloroquinolin-4-yl)amino]benzoate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0299541</sync-id>
  <structure-inchikey>XBVLEIVXSOQLFB-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>400000000002000218002010020000000500004000000000000800000000000000000000000000000000000000020000001000000000000000000001088000000040000004000000000000000000000200000400101000000000000000000000010000140800000000000001000000000000201000000000100000000000000010040000000008040000000000040800000000001000000800000000800000000000004000000000400000800000000400000010c000000a000002800200000000000000000800000000004000000004010008000000004000200000000010000000040000000002040000000000400800000000000000100008040000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKwAAAIABBgBgAAAAAgIGAGAAAAAC
AgcAKAAAAAMDBgBgAAAAAgIGAGAAAAACAgcAIAAAAAMGAGAAAAACAgYAYAAA
AAICCAAoAAAAAwIGACgAAAADBAgAKAAAAAMCBkAoAAAAAwQGQGgAAAADAwEG
QGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAcAaAAAAAMCAQZA
KAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAA
AAMDAQZAKAAAAAMEB0AoAAAAAwMGQGgAAAADAwEGQGgAAAADAwERACAAAAAB
BkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZA
aAAAAAMDAQYAIAAAAAQJACAAAAABCQAgAAAAAQkAIAAAAAELAAEAAQIAAgMA
AwQABAUABQYABgcABwgACAkgCQooAgkLIAsMaAwMDWgMDQ5oDA4PaAwPEGgM
EBEgERIgEhNoDBMUaAwUFWgMFRZoDBYXaAwXGGgMGBloDBkaaAwaG2gMFhwA
Ah0gHR5oDB4faAwfIGgMICFoDCEiaAwhIwAjJAAjJQAjJgAFAAAQC2gMGxJo
DBgTaAwiHWgMQgUAAAAGAAUEAwIBBgwNDg8QCwYUFRYXGBMGGRobEhMYBh4f
ICEiHRcEAAAAAAAAABY=
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:47:21Z</structure-indexed-at>
</compound>
